Scientists tell Commons committee that exposure to colibactin in early life is a potential driver of early onset colorectal cancer
Exposure to a bacterial toxin in early life has emerged as a leading suspect in the rise of bowel cancer amongs those under 50, MPs have heard.
Cases of early onset bowel cancer have doubled in many countries in the past two decades, and while rising obesity and a fall in physical activity are contributors, researchers believe other factors must also be involved.
Dr Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, told the Commons science and technology committee that known risk factors for colorectal cancer, such as obesity, smoking and alcohol, can explain only about half of the cases doctors diagnose.
He said he did not find it “plausible” that the rise in early onset bowel cancer could be entirely explained by risk factors that researchers were already aware of.
Last year scientists identified a toxin called colibactin, produced by some variants of E coli bacteria in the gut, as a potential driver of early onset colorectal cancer. Hallmark mutations caused by the toxin were three times more common in tumours from people under 40 than in those from people over 70.